Longtime Peninsula biotech seeks $200M as stock soars on strength of heart drug trial

The company's stock soared more than 40% Monday as it said it will take a heart drug into a late-stage clinical trial.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news